Our Molecular Genetics Unit is focused on understanding the genetic causes underlying neurodegenerative disorders, and developing new genetic-based biomarkers to aid in disease diagnosis and prognosis. To accomplish this, we use state-of-the-art genetic tools such as next-generation sequencing, ddPCR, etc. applied to patients that have been diagnosed and followed-up by our memory clinic team. We … Read more
In the Memory Unit we perform imaging studies focused on Alzheimer’s disease and other related disorders that allow us to correlate structural, functional or even metabolic brain measures with several cerebrospinal fluid (CSF), clinical or neuropsychologic biomarkers. The neuroimage research line, led by Dr. Fortea, is funded by 3 active grants from the Spanish Government … Read more
List of most recent publications led by the Sant Pau Memory Unit:
What are clinical trials? Clinical trials are used to evaluate the safety and efficacy of new drugs. Trials are divided in four phases: Phase I: During this phase, a drug is tested for the first time in healthy volunteers having previously been assessed for safety and efficacy in laboratory animals. All participants at this stage … Read more
INTRODUCTION The unique composition of the Sant Pau Memory Unit, gathering a team of neurologists, neuropsychologists, research nurses, biologists, engineers and laboratory technicians, has fostered the development of translational research lines that combine clinical observations, direct contact with patients and their relatives, and basic laboratory research. In the last 4 years, the group has contributed … Read more
